EVITA TEST COMPLETE and EVITA TEST GENDER have been developed by the Danish biotech company ARCEDI in close collaboration with several Danish hospitals, the Aarhus University Hospital being the main collaborator.

EVITA TEST COMPLETE is a revolution. Expectant parents now have the opportunity to have complete peace of mind regarding the health of their unborn baby. The test is patented and is based on a simple blood test. This means that there is no risk to the baby or the mother. ARCEDI has developed the technology that makes it possible to isolate fetal cells from the mother’s blood sample. After having performed a series of clinical trials on pregnant women, ARCEDI has launched their prenatal test commercially. This enables them to offer all expectant mothers the opportunity to benefit from this unique technology.

ARCEDI's Vision

ARCEDI’s vision is to deliver a simple, safe, accurate, and non-invasive prenatal diagnostic test for expectant mothers, by analysing the genome of the fetus using fetal cells circulating in the mother’s blood.

We want to provide expectant parents with accurate information about their baby’s chromosomes (genetics), enabling them to have peace of mind, and be well-informed about the future health of their baby.

If you want to know more about ARCEDI, please visit our website.

Contact

ARCEDI has two offices in Denmark:

Main office

Tabletvej 1 | DK-7100 Vejle | Denmark | 

Aarhus

INCUBA | Palle-Juul Jensens Boulevard 82 | DK-8200 Aarhus N | Denmark |

Contact Palle Schelde, Chief Executive Officer for more information

Mail: ps@arcedi.com 
Phone: +45 29 64 15 45